tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CRVO Stock Latest News

CervoMed downgraded to Neutral from Buy at H.C. Wainwright
The FlyCervoMed downgraded to Neutral from Buy at H.C. Wainwright
1M ago
CRVO
CervoMed announces inducement grants under Nasdaq lisitng rule
PremiumThe Fly
CervoMed announces inducement grants under Nasdaq lisitng rule
1M ago
CRVO
CervoMed price target lowered to $4 from $45 at Roth MKM
PremiumThe Fly
CervoMed price target lowered to $4 from $45 at Roth MKM
1M ago
CRVO
CervoMed price target lowered to $12 from $65 at Canaccord
PremiumThe Fly
CervoMed price target lowered to $12 from $65 at Canaccord
1M ago
CRVO
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
PremiumThe Fly
CervoMed downgraded to Underweight from Overweight at Morgan Stanley
1M ago
CRVO
CervoMed downgraded to Neutral from Buy at Chardan
PremiumThe FlyCervoMed downgraded to Neutral from Buy at Chardan
1M ago
CRVO
CervoMed downgraded to Hold from Buy at Brookline
Premium
The Fly
CervoMed downgraded to Hold from Buy at Brookline
1M ago
CRVO
CervoMed downgraded to Hold from Buy at JonesResearch
Premium
The Fly
CervoMed downgraded to Hold from Buy at JonesResearch
1M ago
CRVO
CervoMed downgraded to Hold from Buy at D. Boral Capital
PremiumThe Fly
CervoMed downgraded to Hold from Buy at D. Boral Capital
1M ago
CRVO
CervoMed Faces Setback in Phase 2b Trial
PremiumCompany Announcements
CervoMed Faces Setback in Phase 2b Trial
1M ago
8K
CRVO
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
PremiumThe Fly
CervoMed announces RewinD-LB Phase 2b did not meet primary endpoint
1M ago
CRVO
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
PremiumThe Fly
CervoMed initiated with Buy into ‘binary readout’ at Roth MKM
2M ago
CRVO
CervoMed initiated with a Buy at Roth MKM
PremiumThe FlyCervoMed initiated with a Buy at Roth MKM
2M ago
CRVO
CervoMed initiated with a Buy at H.C. Wainwright
Premium
The Fly
CervoMed initiated with a Buy at H.C. Wainwright
2M ago
CRVO
CervoMed Enhances Transparency with Key Information Access
Premium
Company Announcements
CervoMed Enhances Transparency with Key Information Access
2M ago
8K
CRVO
CervoMed announces ODD granted to neflamapimod by U.S. FDA
PremiumThe Fly
CervoMed announces ODD granted to neflamapimod by U.S. FDA
2M ago
CRVO
CervoMed initiated with a Buy at D. Boral Capital
PremiumThe Fly
CervoMed initiated with a Buy at D. Boral Capital
2M ago
CRVO
CervoMed appoints Ordonez, Rosch as SVPs
PremiumThe Fly
CervoMed appoints Ordonez, Rosch as SVPs
2M ago
CRVO
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
PremiumCompany Announcements
CervoMed Inc. Reports Increased R&D Expenses Amid Ongoing Trials
2M ago
CRVO
CervoMed reports Q3 EPS (55c), consensus (41c)
PremiumThe FlyCervoMed reports Q3 EPS (55c), consensus (41c)
2M ago
CRVO
CRVO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRVO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CRVO
CervoMed announces key takeaways from presentations on neflamapimod
Premium
The Fly
CervoMed announces key takeaways from presentations on neflamapimod
3M ago
CRVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >